Author:
Hohnloser S. H.,Klingenheben T.,Grönefeld G.
Publisher
Springer Berlin Heidelberg
Reference40 articles.
1. ACC/AHA Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (1990) ACC/AHA guidelines for the early management of patients with acute myocardial infarction. Circulation 82: 664–707.
2. Antman EM, Berlin JA (1992) Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine. Circulation 86: 764–773.
3. Chiriboga D, Yarzebski J, Goldberg RL, Gore JM, Alpert JS (1994) Temporal trends (1975 through 1990) in the incidence and case-fafality rates of primary ventricular fibrillation complicating acute myocardial fibrillation: A communitywide perspective. Circulation 89: 998–1003.
4. Corbalan R, Verrier RL, Lown B (1976) Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J 92: 223–230.
5. Fitzgerald JD, Singh BN (1994) Effects of β-Blockers on cardiovascular morbidity and mortality in coronary artery disease. In: Singh BN, Dzau VJ, Vanhoutte PM, Woosley RL (eds) Cardiovascular pharmacology and therapeutics. Churchill Livingstone, New York, pp 511–524.